CTNM CONTINEUM THERAPEUTICS INC-A
2026Q1 · CUSIP 21217B100 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
89
Δ holders QoQ
+9
Breadth percentile
Top 31%
Whale holders
41
Δ whales
+8
Inst. holding value
$399M
New positions
22
Closed positions
13
Price momentum (1Q)
-12.5%
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 0 lit events
No lit events in history
Options Sentiment
Put holders
0
QoQ: -1
Call holders
1
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.94
EPS YoY
-358.7%
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-23.4%
Debt ratio
4.3%
FCF (TTM)
-$58M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.